Literature DB >> 7375822

Phagocytic and chemotactic function of polymorphonuclear and mononuclear leucocytes in patients with recurrent staphylococcal infections.

H A Verbrugh, W C van Dijk, G F Hendrickx, D van der Stadt, J W Stoop, P K Peterson, J Verhoef.   

Abstract

From 21 patients with chronic or recurrent staphylococcal infections, phagocytosis and intracellular killing of Staphylococcus aureus by polymorphonuclear (PMN) and mononuclear (MN) leucocytes were evaluated. Also chemotactic responsiveness and the capacity of their sera to opsonize Staph. aureus was tested. The chemotactic, phagocytic and bactericidal capacity of PMN's and MN's from patients was significantly decreased. The mean uptake of Staph. aureus by patient PMN's and MN's was 65% and 44%, respectively, as compared to 85% and 75% observed with PMN's and MN's from 38 healthy donors. The phagocytic activity of 17/21 patients (81%) was below the normal range. A decreased chemotactic mobility and bactericidal capacity of patient leukocytes was also found and was always accompanied by a decreased rate of ingestion. Although a great variability was noted in the phagocytic capacity of leucocytes from patients tested repeatedly over periods up to 82 weeks, the mean value for phagocytosis remained below the normal range in 10/11 patients included in the follow-up study. Except for 1 patient with dysgammaglobulinemia, sera from the patients contained normal amounts of immunoglobulins and complement (CH50 and C3), and they all effectively opsonized Staph. aureus. The results indicate that defects in leucocyte function may be frequently involved in the pathogenesis of recurrent Staph. aureus infections.

Entities:  

Mesh:

Year:  1980        PMID: 7375822     DOI: 10.3109/inf.1980.12.issue-2.07

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses.

Authors:  Lawrence Y Lee; Yuko J Miyamoto; Bradley W McIntyre; Magnus Höök; Kirk W McCrea; Damien McDevitt; Eric L Brown
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Bestatin treatment for the correction of granulocyte dysfunction in patients with recurrent furunculosis.

Authors:  L Mattsson; H Blomgren; B Holmgren; C Jarstrand
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.